Healthcare resource utilization and exacerbations in patients with chronic obstructive pulmonary disease treated with nebulized glycopyrrolate in the USA: a real-world data analysis.
Xiaoli NiuVictoria DivinoSanjay SharmaMitch DekovenVamshi Ruthwik AnupindiCarole DembekPublished in: Journal of medical economics (2021)
Among patients initiating GLY in a real-world setting, COPD medications, hospitalizations, other HRU, and exacerbations decreased after treatment initiation compared with the 6-month pre-index period.